[MNPR] YoY Quarter Result on 30-Sep-2022 [#Q3]

Stock
[MNPR] Monopar Therapeutics Inc.
Announcement Date
10-Nov-2022
Financial Year
2022
Quarter
30-Sep-2022 [#Q3]
Profit Trend
QoQ- 13.11%
YoY- 2.36%
Quarter Report
MNPR's Result
MNPR's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -1,304,276 -1,954 -2,400 -2,458 -1,639 -736 -640 255.65%
Tax 0 112,146 -2,407 -2,459 -1,648 -759 -668 -
NP -1,304,276 -1,954 -2,400 -2,458 -1,639 -736 -640 255.65%
Tax Rate - - - - - - - -
Total Cost 1,304,276 1,954 2,400 2,458 1,639 736 640 255.65%
Ratio Analysis
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
EPS -0.37 -0.14 -0.19 -0.20 -0.15 -0.07 -0.06 35.38%
EPS Diluted -0.37 -0.14 -0.19 -0.20 -0.15 -0.07 -0.06 35.38%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.